Trial intelligence / Profile preview

MATCH study of melatonin, temazepam, and placebo for sleep problems in hospitalized older patients

NL-OMON21870Suspended

Sponsor
Prof.dr. S.E.J.A. de Rooij Email: [email protected] Telefoon: (050) 3613921 Adress Hanzeplein 1 9713 GZ Groningen Kamer Z3.16, intern postadres: AA-43 Netherlands
Start
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in sleep disorder and Insomnia comparing Melatonin, Temazepam and Placebo (3 arms). Primary endpoint: Sleep quality. Started Jan 2018; status: suspended.

02

Drugs

melatonintemazepam
03

Conditions

sleep disorderInsomnia

Beyond the preview

Go deeper on NL-OMON21870.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON21870.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call